TEL: +86 571 56623320    EMAIL: [email protected]

Recombinant Rabbit Anti-CD19 Monoclonal Antibody
Recombinant Rabbit Anti-CD19 Monoclonal Antibody
B4; CVID3; CD19_HUMAN; CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD19_MOUSE; CD19 molecule; CD19 antigen
Total $470.0
(Vip priceV)
Regular members: $376.0
  • NO.:SLA0375M
    React Species:Mouse
    Immunogen Species:Rat
    Clonality:Monoclonal
    Applications:Flow-Cyt
    Gene name:CD19
  • Goods click count:11
  • Product Spec:
  • Quantity: - +
  • Limit points for buying:0 Points
  • Manual
  • Add to cart Inquiry Add to favorite
All categories

Details

 

Product NameRecombinant Rabbit Anti-CD19 Monoclonal Antibody
Cat No.SLA0375M
Chinese Name小鼠CD19单克隆抗体
AliasB4; CVID3; CD19_HUMAN; CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD19_MOUSE; CD19 molecule; CD19 antigen
Host SpeciesRat
IsotypeRat IgG2a,k
ClonalityMonoclonal
Clone No.5C7
React SpeciesMouse
ApplicationsFlow-Cyt (1:50-100)
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Purificationaffinity purified by Protein G
Predicted MW.59 kDa
Observed MW.90 kDa
Subcellular LocationMembrane
Storage0.01M PBS (pH7.4).
Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
BackgroundThis gene encodes a member of the immunoglobulin gene superfamily. Expression of this cell surface protein is restricted to B cell lymphocytes. This protein is a reliable marker for pre-B cells but its expression diminishes during terminal B cell differentiation in antibody secreting plasma cells. The protein has two N-terminal extracellular Ig-like domains separated by a non-Ig-like domain, a hydrophobic transmembrane domain, and a large C-terminal cytoplasmic domain. This protein forms a complex with several membrane proteins including complement receptor type 2 (CD21) and tetraspanin (CD81) and this complex reduces the threshold for antigen-initiated B cell activation. Activation of this B-cell antigen receptor complex activates the phosphatidylinositol 3-kinase signalling pathway and the subsequent release of intracellular stores of calcium ions. This protein is a target of chimeric antigen receptor (CAR) T-cells used in the treatment of lymphoblastic leukemia. Mutations in this gene are associated with the disease common variable immunodeficiency 3 (CVID3) which results in a failure of B-cell differentiation and impaired secretion of immunoglobulins. CVID3 is characterized by hypogammaglobulinemia, an inability to mount an antibody response to antigen, and recurrent bacterial infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]
AttentionThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

 

FOR RESEARCH USE ONLY. Not for use in diagnostic or therapeutic procedures.

Partial purchase records(bought amounts latest0)

No one bought this product
Total 0 records, divided into1 pages First Prev Next Last

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha

Call us

+86 571 56623320

Address

Room 1-315, Kongle Changqing Building, No. 160 Guangye Road,Gongshu District, Hangzhou City, Zhejiang Province, China

Join Us with

Leave a message
* To protect against spam, please pass the CAPTCHA test below.
© 2005-2026 SUNLONG BIOTECH CO., LTD Copyright, All Rights Reserved.